9,192 followers
Retracted in 2016, cited every year since retraction.
Retracted in 2016, cited every year since retraction.
We've detected a paper from Frontiers in Oncology that cites a retracted paper post-retraction. Citing paper: https://t.co/QR17rwx3e6 Retracted paper: https://t.co/PaVMAuaXf0
ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma https://t.co/lTRWXfg78q
New research: ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma: Aims Anti-angiotherapy (Bevacizumab) is currently regarded as a promising option for glioma patients who are resistant to temozolomide (TMZ)… https://t.co/RFHXQdD